Login / Signup

Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.

Kathryn T MaplesKevin H HallNisha S JosephCraig C HofmeisterVilas A GuptaMadhav V DhodapkarJonathan L KaufmanAjay K NookaSagar Lonial
Published in: Blood cancer journal (2023)
Keyphrases
  • multiple myeloma